Search - tctmd.com

Displaying 321 - 329 of 329

Sort: Relevancy | Date

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

Presenter: Josep Rodes-Cabau

October 22, 2012

Presentation TCT 2012

The New 320-Row Computed Tomography With Lower Radiation Exposure to Rule-out Coronary Artery Disease in Patients with Atrial Fibrillation

Presenter: Francesco Pelliccia, Antonietta Evangelista, Amedeo Pergolini, Vincenzo Pasceri, Nicola Viceconte, Giuseppe Pannarale, Salvatore Varrica, Susanna Romitelli, Massimo Pellegrini, Carlo Gaudio

January 03, 2012

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

News Conference News

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

November 06, 2011

Video

» Interview

TCT 2018: Dr. C. Michael Gibson talks with Dr. Dominick Angiolillo about the 2018 North American Consensus Statement for atrial fibrillation patients undergoing PCI

September 23, 2018

Advertisement

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

New-Onset Atrial Fibrillation After TAVR: More Frequent than Reported and a Possible Predictor of Stroke

The New 320-Row Computed Tomography With Lower Radiation Exposure to Rule-out Coronary Artery Disease in Patients with Atrial Fibrillation

New Stem Cell Therapies Promising in Severe Heart Disease

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

TCT 2018: Dr. C. Michael Gibson talks with Dr. Dominick Angiolillo about the 2018 North American Consensus Statement for atrial fibrillation patients undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content